FIELD: pharmacology.
SUBSTANCE: group of inventions refers to pharmaceutical industry and discloses a natural biocomposite powder. The biocomposite powder contains 20-95% (w/w) chitin glucan (CGC) complex and up to 50% mannose-containing polysaccharides extracted from Pichia pastoris yeast biomass, where the particle size of the biocomposite powder is in the range of 5 to 1500 mcm, and where the apparent bulk density of the biocomposite powder is from 0.05 to 1.0 g/cm3. It has also been proposed to use the said biocomposite powder as an excipient in pharmaceutical, cosmetic or food industries.
EFFECT: group of inventions allows to obtain a unique additive, which can be used as a multifunctional excipient in the pharmaceutical industry.
52 cl, 1 dwg, 3 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR COMBINED PRODUCTION OF CHITIN-GLUCAN COMPLEX AND POLYMERS CONTAINING GLUCOSE, MANNOSE AND/OR GALACTOSE BY FERMENTING Pichia pastoris YEAST | 2009 |
|
RU2562172C2 |
METHOD OF PRODUCING BIOCOMPOSITE FODDER ADDITIVE FOR FARM ANIMALS AND POULTRY | 2019 |
|
RU2721800C1 |
COMPOSITION AND METHOD OF PRODUCING BIOCOMPOSITE FODDER ADDITIVE FOR FARM ANIMALS AND POULTRY | 2019 |
|
RU2721795C1 |
AGENT FOR BINDING FATS OBTAINED FROM BIOMASS, FORMED DURING BREWING | 2013 |
|
RU2608233C2 |
METHOD OF PREPARING SURFACE ANTIGEN OF HEPATITIS B VIRUS (HBS AG), MONOCLONAL ANTIBODIES CB-HEPI, SURFACE ANTIGEN OF HEPATITIS B VIRUS (HBS AG) AND METHOD OF PREPARING HYBRID CLONE 48/1/574 PRODUCING MONOCLONAL ANTIBODIES CB-HEPI | 1992 |
|
RU2128707C1 |
METHOD OF PYRUVIC ACID PRODUCING | 1994 |
|
RU2123529C1 |
1,3-DIHYDROIMIDAZOLE-2-THIONE DERIVATIVES FOR USE IN TREATING PULMONARY ARTERIAL HYPERTENSION AND LUNG INJURY | 2013 |
|
RU2718055C2 |
CLONING, EXPRESSION IN YEAST, CLEANING AND BIOLOGICAL ACTIVITY OF ELONGATION REGION OF ALPHA'-SUBUNITS OF SOYA BEAN 7S-GLOBULIN, INVOLVED IN CHOLESTEROL HOMEOSTASIS IN Hep G2 CELLS | 2010 |
|
RU2558259C2 |
FERMENTATION MEDIUM AND METHOD OF PRODUCTION OF RECOMBINANT PROTEINS | 2009 |
|
RU2491345C2 |
AMINO ACID COMPOSITION FOR USE IN TREATING OF PDD | 2014 |
|
RU2681845C2 |
Authors
Dates
2017-09-25—Published
2013-03-15—Filed